Literature DB >> 17880334

Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome: a report from the NHLBI Dynamic Registry.

Vankeepuram S Srinivas1, Faith Selzer, Robert L Wilensky, David R Holmes, Howard A Cohen, E Scott Monrad, Alice K Jacobs, Sheryl F Kelsey, David O Williams, Kevin E Kip.   

Abstract

When percutaneous coronary intervention (PCI) is performed in patients with multivessel coronary disease, a targeted revascularization (TR) of diseased vessels is performed more often than complete revascularization (CR). We compared baseline characteristics and 1-year outcomes of patients undergoing TR by operator choice (n = 1,091), TR because CR was unachievable (n = 375), and CR (n = 315) in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry. Patients receiving TR because CR was unachievable were older, had more comorbidities, worse ejection fraction, less often received 2b/3a inhibitors and stents, and less frequently achieved complete angiographic success than either patients receiving TR by choice or CR. Despite these considerable differences, cumulative rates of 1-year mortality, the need for repeat PCI, or coronary bypass surgery were similar in patients who received CR, TR by choice, or TR because CR was unachievable. In multivariable models, after adjustment for clinical characteristics and propensity to receive CR, the hazard ratio for CR versus TR was 1.10 (95% CI: 0.58-2.10) for 1-year mortality; 0.89 (0.60-1.32) for repeat PCI, and 0.92 (0.66-1.29) for repeat PCI or coronary bypass surgery. In conclusion, despite the presence of more unfavorable characteristics, patients undergoing TR demonstrate 1-year outcomes equivalent to those having CR, supporting its continued use in selected patients.

Entities:  

Mesh:

Year:  2007        PMID: 17880334     DOI: 10.1111/j.1540-8183.2007.00273.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  5 in total

Review 1.  Revascularization Strategies for Non-ST-Elevation Myocardial Infarction.

Authors:  Bennet George; Naoki Misumida; Khaled M Ziada
Journal:  Curr Cardiol Rep       Date:  2019-04-10       Impact factor: 2.931

2.  Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score.

Authors:  Philippe Généreux; Tullio Palmerini; Adriano Caixeta; Gregg Rosner; Philip Green; Ovidiu Dressler; Ke Xu; Helen Parise; Roxana Mehran; Patrick W Serruys; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2012-04-04       Impact factor: 24.094

3.  Therapeutic options in coronary artery disease: focusing on the guidelines.

Authors:  Leonard Schwartz
Journal:  Can J Cardiol       Date:  2009-01       Impact factor: 5.223

4.  Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries.

Authors:  Lakshmi Venkitachalam; Kevin E Kip; Faith Selzer; Robert L Wilensky; James Slater; Suresh R Mulukutla; Oscar C Marroquin; Peter C Block; David O Williams; Sheryl F Kelsey
Journal:  Circ Cardiovasc Interv       Date:  2008-12-15       Impact factor: 6.546

Review 5.  Impact of Incomplete Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Authors:  Vinayak Nagaraja; Sze-Yuan Ooi; James Nolan; Adrian Large; Mark De Belder; Peter Ludman; Rodrigo Bagur; Nick Curzen; Takashi Matsukage; Fuminobu Yoshimachi; Chun Shing Kwok; Colin Berry; Mamas A Mamas
Journal:  J Am Heart Assoc       Date:  2016-12-16       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.